Bringing the Oncology Community Together
Giants of Cancer Care 2015
FDA Expands Approval of Ibrutinib to Waldenström’s Macroglobulinemia
The FDA has expanded the approval of ibrutinib (Imbruvica) for the treatment of patients with Waldenström’s macroglobulinemia (WM), according to a press release.
PD-1 Inhibition: The Changing Treatment Paradigm for Melanoma
An increased understanding of tumor immunology has led to seven new melanoma drug approvals since 2011, including the recent approvals of the PD-1 inhibitors nivolumab (Opdivo) and pembrolizumab (Keytruda).
More Positive Data for BRAF/MEK Combo in Melanoma, But Debate Continues
The combination of trametinib (Mekinist) and dabrafenib (Tafinlar) improved overall survival (OS) compared with vemurafenib alone in patients with unresectable (stage IIIC) or metastatic (stage IV) BRAFV600E/K mutation-positive cutaneous melanoma.
Full Approval Sought for Carfilzomib in Multiple Myeloma
A supplemental New Drug Application has been submitted to the FDA for the full regulatory approval of carfilzomib as a treatment for patients with relapsed multiple myeloma.
Incyte Medical Officer Elaborates on Ruxolitinib Benefit for Polycythemia Vera
For additional insight on the published RESPONSE data and the use of ruxolitnib to treat polycythemia vera, we reached out to Richard Levy, MD, executive vice president and chief drug development and medical officer at Incyte, the company that co-manufactures ruxolitinib with Novartis.
Questions Remain Regarding Combinations and Sequencing in pNETs
To gain insight into the unanswered questions surrounding the treatment of pNETs, OncLive interviewed Pamela L. Kunz, MD, Assistant Professor of Medicine/Oncology at Stanford University.
Brahmer Expects Rapid Approval for First PD-1 Inhibitor in Lung Cancer
Immune checkpoint inhibitors targeted against PD-1 and its ligand PD-L1 have rapidly advanced as treatments for patients with melanoma and non–small cell lung cancer (NSCLC), following their initial debut in 2012.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2014
Intellisphere, LLC. All Rights Reserved.